OKYO Pharma Limited Sponsored ADR's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; OKYO Pharma Limited Sponsored ADR is scheduled to report earnings on July 30, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 22	Mar 22	Sep 21	Mar 21	Sep 20
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	-	-	-	-	-
EBITDA	-	-	-	-	-
Net Income Common Stockholders	-	-	-	-	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	£ 633.63K	£ 2.70M	£ 3.85M	£ 4.99M	£ 5.76M
Total Assets	£ 1.59M	£ 4.30M	£ 4.18M	£ 5.14M	£ 5.84M
Total Debt	£ 0.00	£ 0.00	£ 60.73K	£ 71.56K	£ 22.52K
Net Debt	£ -633.63K	£ -2.70M	£ -3.79M	£ -4.92M	£ -5.74M
Total Liabilities	£ 1.90M	£ 1.35M	£ 494.83K	£ 1.28M	£ 342.75K
Stockholders Equity	£ -309.68K	£ 2.95M	£ 3.68M	£ 3.85M	£ 5.50M
Cash Flow	-
Free Cash Flow	-	-	-	-	-
Operating Cash Flow	-	-	-	-	-
Investing Cash Flow	-	-	-	-	-
Financing Cash Flow	-	-	-	-	-

Currency in GBP

OKYO Pharma Limited Sponsored ADR Earnings and Revenue History

Income Statement >

OKYO Pharma Limited Sponsored ADR Debt to Assets

Balance Sheet >

OKYO Pharma Limited Sponsored ADR Cash Flow

Cash Flow >

OKYO Pharma Limited Sponsored ADR Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing